مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
LibKey Link

مصطلحات الفهرس: multicenter study, neutropenia/si [Side Effect], outcome assessment, pancreas adenocarcinoma/di [Diagnosis], pancreas adenocarcinoma/dt [Drug Therapy], patient care, peripheral neuropathy/si [Side Effect], phase 3 clinical trial, priority journal, progression free survival, thrombocytopenia/si [Side Effect], tumor localization, very elderly, vomiting/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/an [Drug Analysis], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pd [Pharmacology], CA 19-9 antigen/ec [Endogenous Compound], gemcitabine/ae [Adverse Drug Reaction], gemcitabine/ct [Clinical Trial], gemcitabine/an [Drug Analysis], gemcitabine/cm [Drug Comparison], gemcitabine/dt [Drug Therapy], gemcitabine/pd [Pharmacology], unclassified drug, gemcitabine plus paclitaxel/ae [Adverse Drug Reaction], gemcitabine plus paclitaxel/ct [Clinical Trial], gemcitabine plus paclitaxel/an [Drug Analysis], gemcitabine plus paclitaxel/cm [Drug Comparison], gemcitabine plus paclitaxel/dt [Drug Therapy], gemcitabine plus paclitaxel/pd [Pharmacology], overall survival, adult, aged, anemia/si [Side Effect], antigen detection, antineoplastic activity, article, Australia, cancer survival, cohort analysis, controlled study, drug efficacy, drug safety, fatigue/si [Side Effect], female, hematologic disease/si [Side Effect], human, human tissue, informed consent, leukopenia/si [Side Effect], lung metastasis/co [Complication], major clinical study, male, metastasis potential, middle aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37024Test
Asia-Pacific Journal of Clinical Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: phase 1 clinical trial (topic), phase 2 clinical trial (topic), priority journal, prostate cancer/dt [Drug Therapy], public hospital, randomized controlled trial, abiraterone/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], cetuximab/ct [Clinical Trial], cetuximab/dt [Drug Therapy], fulvestrant/dt [Drug Therapy], temsirolimus/ct [Clinical Trial], temsirolimus/dt [Drug Therapy], phase 3 clinical trial (topic), advanced cancer/dt [Drug Therapy], Australia, breast cancer/dt [Drug Therapy], cancer patient, colorectal cancer/dt [Drug Therapy], compassionate use, drug industry, human, kidney cancer/dt [Drug Therapy], letter, overall survival, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27526Test
LibKey Link

مصطلحات الفهرس: solid tumor/dt [Drug Therapy], adolescent, adult, aged, anemia/co [Complication], anemia/dt [Drug Therapy], anemia/th [Therapy], article, Australia, blood transfusion, breast cancer/dt [Drug Therapy], breast cancer/rt [Radiotherapy], cancer combination chemotherapy, clinical trial, confidence interval, disease severity, female, follow up, health survey, hematologic malignancy/dt [Drug Therapy], hematologic malignancy/rt [Radiotherapy], hemoglobin determination, human, iron therapy, leukemia/dt [Drug Therapy], leukemia/rt [Radiotherapy], lymphoma/dt [Drug Therapy], lymphoma/rt [Radiotherapy], major clinical study, male, multicenter study, myeloma/dt [Drug Therapy], myeloma/rt [Radiotherapy], prediction, prevalence, prospective study, rank sum test, solid tumor/rt [Radiotherapy], treatment outcome, urogenital tract cancer/dt [Drug Therapy], urogenital tract cancer/rt [Radiotherapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/dt [Drug Therapy], erythropoietin/ct [Clinical Trial], erythropoietin/dt [Drug Therapy], iron/ct [Clinical Trial], iron/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28745Test
Medical Journal of Australia
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug tolerability, endometrium cancer/dt [Drug Therapy], endometrium cancer/rt [Radiotherapy], endometrium cancer/su [Surgery], endometrium cancer/th [Therapy], histopathology, human, hyperthermic therapy, fulvestrant/ct [Clinical Trial], laparoscopic surgery, laparotomy, meta analysis, nonhuman, postmenopause, review, salpingooophorectomy, sentinel lymph node biopsy, anastrozole/ct [Clinical Trial], anastrozole/dt [Drug Therapy], anastrozole/po [Oral Drug Administration], angiogenesis inhibitor/dt [Drug Therapy], angiogenesis inhibitor/pd [Pharmacology], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cb [Drug Combination], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pr [Pharmaceutics], antineoplastic agent/pd [Pharmacology], aromatase inhibitor/ct [Clinical Trial], aromatase inhibitor/dt [Drug Therapy], aromatase inhibitor/po [Oral Drug Administration], cisplatin/ct [Clinical Trial], cisplatin/cb [Drug Combination], cisplatin/cm [Drug Comparison], cisplatin/dt [Drug Therapy], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/ct [Clinical Trial], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/dt [Drug Therapy], doxorubicin/pr [Pharmaceutics], epirubicin/ct [Clinical Trial], epirubicin/cb [Drug Combination], epirubicin/dt [Drug Therapy], everolimus/ct [Clinical Trial], everolimus/dt [Drug Therapy], everolimus/po [Oral Drug Administration], fluorouracil/ct [Clinical Trial], fluorouracil/cb [Drug Combination], fluorouracil/dt [Drug Therapy], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/dt [Drug Therapy], gestagen/po [Oral Drug Administration], gestagen/pa [Parenteral Drug Administration], gestagen/pr [Pharmaceutics], gonadorelin derivative/dt [Drug Therapy], letrozole/dt [Drug Therapy], liposome/pr [Pharmaceutics], mammalian target of rapamycin/ec [Endogenous Compound], medroxyprogesterone acetate/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/dt [Drug Therapy], megestrol acetate/ct [Clinical Trial], megestrol acetate/dt [Drug Therapy], paclitaxel/ct [Clinical Trial], paclitaxel/cb [Drug Combination], paclitaxel/dt [Drug Therapy], rapamycin/pd [Pharmacology], tamoxifen/ct [Clinical Trial], tamoxifen/cb [Drug Combination], tamoxifen/dt [Drug Therapy], temsirolimus/ct [Clinical Trial], temsirolimus/dt [Drug Therapy], temsirolimus/pd [Pharmacology], trastuzumab/ct [Clinical Trial], trastuzumab/dt [Drug Therapy], trastuzumab/pd [Pharmacology], unclassified drug, vasculotropin, caelix, vasculotropin trap/ct [Clinical Trial], vasculotropin trap/dt [Drug Therapy], vasculotropin trap/pd [Pharmacology], hysterectomy, fulvestrant/dt [Drug Therapy], antineoplastic activity, bone marrow toxicity/si [Side Effect], cancer chemotherapy, cancer hormone therapy, cancer mortality, cancer radiotherapy, cancer staging, cancer survival, cardiotoxicity/si [Side Effect], clinical trial, conservative treatment, drug delivery system, drug efficacy, drug formulation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32265Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: leukemia remission, major clinical study, male, mucosa inflammation/si [Side Effect], neutropenia/dt [Drug Therapy], neutropenia/si [Side Effect], patient selection, thrombocytopenia/dt [Drug Therapy], thrombocytopenia/si [Side Effect], treatment outcome, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cb [Drug Combination], antineoplastic agent/dt [Drug Therapy], asparaginase/ae [Adverse Drug Reaction], asparaginase/ct [Clinical Trial], asparaginase/cb [Drug Combination], asparaginase/dt [Drug Therapy], ceftazidime/dt [Drug Therapy], cytarabine/ae [Adverse Drug Reaction], cytarabine/ct [Clinical Trial], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], daunorubicin/ae [Adverse Drug Reaction], daunorubicin/ct [Clinical Trial], daunorubicin/cb [Drug Combination], daunorubicin/dt [Drug Therapy], dexamethasone/ae [Adverse Drug Reaction], dexamethasone/ct [Clinical Trial], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], etoposide/ae [Adverse Drug Reaction], etoposide/ct [Clinical Trial], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], granulocyte colony stimulating factor/dt [Drug Therapy], methotrexate/ae [Adverse Drug Reaction], methotrexate/ct [Clinical Trial], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], prednisolone/ae [Adverse Drug Reaction], prednisolone/ct [Clinical Trial], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], retinoic acid/ae [Adverse Drug Reaction], retinoic acid/ct [Clinical Trial], retinoic acid/cb [Drug Combination], retinoic acid/dt [Drug Therapy], tioguanine/ae [Adverse Drug Reaction], tioguanine/ct [Clinical Trial], tioguanine/cb [Drug Combination], tioguanine/dt [Drug Therapy], vincristine/ae [Adverse Drug Reaction], vincristine/ct [Clinical Trial], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], female, acute granulocytic leukemia/di [Diagnosis], acute granulocytic leukemia/dt [Drug Therapy], acute granulocytic leukemia/ep [Epidemiology], acute granulocytic leukemia/su [Surgery], acute lymphocytic leukemia/di [Diagnosis], acute lymphocytic leukemia/dt [Drug Therapy], acute lymphocytic leukemia/ep [Epidemiology], acute lymphocytic leukemia/su [Surgery], adult, aged, article, bone marrow transplantation, cancer chemotherapy, clinical protocol, clinical trial, fever/dt [Drug Therapy], fever/si [Side Effect], human, intrathecal drug administration, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], phase 1 clinical trial, priority journal, proteinuria/si [Side Effect], QT prolongation/si [Side Effect], randomized controlled trial, side effect/si [Side Effect], solid tumor/dt [Drug Therapy], thrombocytopenia/si [Side Effect], treatment response, visual impairment/si [Side Effect], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pk [Pharmacokinetics], antineoplastic agent/pd [Pharmacology], caspase, cytokeratin 18/ec [Endogenous Compound], unclassified drug, von Willebrand factor/ec [Endogenous Compound], cyt997/ae [Adverse Drug Reaction], cyt997/ct [Clinical Trial], cyt997/do [Drug Dose], cyt997/dt [Drug Therapy], cyt997/iv [Intravenous Drug Administration], cyt997/pk [Pharmacokinetics], cyt997/pd [Pharmacology], male, abdominal pain/si [Side Effect], adult, advanced cancer, aged, anemia/si [Side Effect], area under the curve, article, clinical article, clinical trial, controlled clinical trial, controlled study, creatinine blood level, cytotoxicity, drug dose escalation, drug half life, drug mechanism, drug metabolism, drug safety, drug tolerability, dyspnea/si [Side Effect], female, headache/si [Side Effect], human, hypertension/si [Side Effect], hypoxia/si [Side Effect], lymphocytopenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31040Test
Click here for full text options
LibKey Link